(Alliance News) - Stock prices in London were higher at midday on Wednesday, as the FTSE 100 achieved a new record and outperformed European peers after healthy results for GSK and Next. Read More
(Alliance News) - Stock prices in London opened higher on Wednesday and hit a new intra-day record after a swathe of well-received reports from Glencore, Next and GSK. Read More
(Alliance News) - GSK PLC on Wednesday raised guidance after a strong third quarter, which saw sales in all three divisions beat expectations. Read More
(Alliance News) - GSK raises its outlook for revenue and profit, Next ups its guidance as third quarter sales beat expectations, while Primary Health Properties' acquisition of Assura is cleared by the UK competition regulator. Read More
(Alliance News) - GSK on Tuesday said it will pay up to USD745 million, plus royalties, as part of a license deal with US biotechnology company Empirico Inc. Read More
(Alliance News) - Stock prices in London were mixed on Monday morning, as the UK lagged a broader rally amid hopes of a trade deal between the US and China. Read More
(Alliance News) - GSK PLC on Monday announced an agreement with Syndivia that grants GSK exclusive worldwide rights to develop and commercialise a preclinical antibody-drug conjugate for metastatic castration-resistant prostate cancer. Read More
(Alliance News) - HSBC sets aside USD1.1 billion for a Luxembourg court ruling related to the Bernard Madoff fraud case, while the UK competition regulator asks for remedies to approve the Greencore-Bakkavor merger. Read More
(Alliance News) - The FTSE 100 hit another record peak on Friday fuelled by weaker-than-expected US inflation data, a bunch of optimistic UK economic reports and strong results from NatWest. Read More
(Alliance News) - Stock prices in London opened slightly higher on Friday, supported by stronger-than-expected UK retail sales data, while investors looked ahead to a slew of PMI releases and US inflation figures later in the day. Read More
(Alliance News) - GSK PLC said Thursday its drug Blenrep has been approved by the US Food & Drug Administration for the treatment of adults with relapsed or refractory multiple myeloma, the third most common blood cancer globally. Read More
(Alliance News) - NatWest Group upgraded its 2025 guidance after reporting a strong third-quarter profit rise, while GSK secured US approval for its multiple myeloma drug Blenrep. Read More
(Alliance News) - GSK PLC and Nasdaq-listed Alector Inc on Wednesday said they won't proceed with a study into a possible dementia treatment after trial results failed to meet hopes. Read More
(Alliance News) - GSK PLC on Tuesday announced a double dose of good news regarding shingles drug, Shingrix, and urinary tract infection treatment, tebipenem HBr. Read More
(Alliance News) - Pearson reaffirms its 2025 outlook as sales accelerated and Smiths Group agrees to sell its Interconnect division for GBP1.3 billion to Molex. Man Group reports higher assets under management at the end of the third quarter. Read More
(Alliance News) - GSK PLC on Tuesday said the China National Medical Products Administration has approved its Shingrix injection for immunocompromised adults. Read More
